Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by jfm1330


T.TH

RE:RE:Silver lining

How will they attract somebody for the oncology manager they reupped the job...

December 1, 2022

T.TH

RE:RE:RE:Silver lining

Fooled again by this company. Forget the 4-7 x dose. In ligth of the actual...

December 1, 2022

T.TH

RE:RE:RE:Jones Report is very good

Yes, I like seeing it because up to now, only PDCs with radionuclides proved...

November 30, 2022

T.TH

RE:Jones Report is very good

I think that the only way they were able to get two analysts to write reports...

November 30, 2022

T.TH

RE:RE:RE:RE:RE:Cantor report effect

Still no news. All we have is indirect signs that something positive is going...

November 22, 2022

T.TH

RE:RE:RE:RE:RE:RE:Soleus influence?

I got my 8th treatement with Lu-177-Dotatate today. Two hours of road in a...

November 16, 2022

T.TH

RE:RE:Cydy pulling out of Hiv MDR

They released the news friday at the end of the day. It will go down monday...

October 29, 2022

T.TH

RE:RE:RE:RE:RE:News out 👀

The big takeaway from this poster is the fact that cancer stages don't...

October 26, 2022

T.TH

RE:RE:RE:Recent study

I gave a reference a few weeks ago pointing to high sortilin expression in...

October 25, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Example of PR for Proof Of Concept

https://www.rcgt.com/en/tax-planning-guide/sections/section-5-employees/stock...

October 24, 2022

T.TH

RE:RE:RE:RE:RE:Spider Plot

What would have been much better than a poster presentation of sortilin...

October 19, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Designing the basket trials

Other interesting bit from Levesque near the end of the CC answering Doug Loe...

October 18, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Designing the basket trials

I was so disgusted with the press release last week that I just listen the...

October 18, 2022

T.TH

RE:RE:RE:RE:New Corporate Presentation Out

Can you explain to me why your friends can talk with management and come away...

October 14, 2022

T.TH

RE:New Corporate Presentation Out

Finally it was pointless to hope for something different. All we got was old...

October 14, 2022

T.TH

Poster on Sortilin expression based on microarray

They come out with old news. We are not interested in that but in sortilin...

October 12, 2022

T.TH

RE:RE:RE:RE:RE:RE:“Low dose docetaxel”

I don't know how often I will have to repeat it, it is not clear what...

October 11, 2022

T.TH

RE:RE:Recent study

Another reference confirms that sortilin is overexpressed and involved in...

October 7, 2022

T.TH

RE:RE:RE:RE:Meanwhile AKRO.....a 2B$ company

I will say it again, you cannot talk about having the key without knowing if...

October 7, 2022

T.TH

RE:RE:RE:RE:RE:Share Price Appreciation Expectations?

Sorry, at this point stable disease results won't be enough to move the...

October 6, 2022

Featured Company